Evidence map›Paper›PMID 39370595›Full record

ArticleAdvanced healthcare materials2024

Environmentally Controlled Microfluidic System Enabling Immune Cell Flow and Activation in an Endothelialised Skin-On-Chip.

Elisabetta Michielon, Matteo Boninsegna, Taco Waaijman, Dario Fassini, Sander W Spiekstra, Jeremy Cramer, Pierre Gaudriault, János Kodolányi, Tanja D de Gruijl, Antoni Homs-Corbera and 1 more

Abstract read
In one paragraph

Article in Advanced healthcare materials, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. CD4Frontiers in immunology · 2026
    Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Elisabetta MichielonDepartment of Molecular Cell Biology and Immunology, Amsterdam UMC Location Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, 1081 HV, The Netherlands.ORCID 0000-0002-2876-397X
Matteo BoninsegnaCherry Biotech SAS, 14 Rue De La Beaune, Bâtiment A, 2ème Étage, Montreuil, 93100, France.ORCID 0000-0003-3070-3455
Taco WaaijmanDepartment of Molecular Cell Biology and Immunology, Amsterdam UMC Location Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, 1081 HV, The Netherlands.ORCID 0009-0002-8661-657X
Dario FassiniCherry Biotech SAS, 14 Rue De La Beaune, Bâtiment A, 2ème Étage, Montreuil, 93100, France.ORCID 0000-0001-6608-5121
Sander W SpiekstraDepartment of Molecular Cell Biology and Immunology, Amsterdam UMC Location Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, 1081 HV, The Netherlands.ORCID 0000-0002-8178-5318
Jeremy CramerCherry Biotech SAS, 14 Rue De La Beaune, Bâtiment A, 2ème Étage, Montreuil, 93100, France.ORCID 0000-0001-7084-6755
Pierre GaudriaultCherry Biotech SAS, 14 Rue De La Beaune, Bâtiment A, 2ème Étage, Montreuil, 93100, France.ORCID 0000-0001-9791-9563
János KodolányiDepartment of Dental Material Science, Academic Centre for Dentistry Amsterdam (ACTA), University of Amsterdam and Vrije Universiteit, Amsterdam, 1081 LA, The Netherlands.ORCID 0000-0001-5710-0537
Tanja D de GruijlAmsterdam institute for Infection and Immunity, Amsterdam University Medical Center, Vrije Universiteit, Amsterdam, The Netherlands.ORCID 0000-0003-1464-8978
Antoni Homs-CorberaCherry Biotech SAS, 14 Rue De La Beaune, Bâtiment A, 2ème Étage, Montreuil, 93100, France.ORCID 0000-0001-7889-273X
Susan GibbsDepartment of Molecular Cell Biology and Immunology, Amsterdam UMC Location Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, 1081 HV, The Netherlands.ORCID 0000-0002-3446-6138

Funding

Eurostars E!11275HORIZON 2020 Marie Skłodowska-Curie Actions 766181HORIZON EUROPE European Innovation Council 101099775
6 · The paper itself

Abstract

Integration of reconstructed human skin (RhS) into organ-on-chip (OoC) platforms addresses current limitations imposed by static culturing. This innovation, however, is not without challenges. Microfluidic devices, while powerful, often encounter usability, robustness, and gas bubble issues that hinder large-scale high-throughput setups. This study aims to develop a novel re-usable multi-well microfluidic adaptor (MMA) with the objective to provide a flexible tool for biologists implementing complex 3D biological models (e.g., skin) while enabling simultaneous user control over temperature, medium flow, oxigen (O

Indexed as

Lab-On-A-Chip DevicesSkinHumansimmune cell activationimmune cell flowmicrofluidicsorgan‐on‐chipreconstructed human skinskin‐on‐chip

Identifiers

PMID39370595
PMCPMC11582514

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.